Literature DB >> 14575311

Contractile effects of adenovirally-mediated increases in SERCA2a activity: a comparison between adult rat and rabbit ventricular myocytes.

Babar Chaudhri1, Federica del Monte, Roger J Hajjar, Sian E Harding.   

Abstract

Adenoviral vectors have been successfully used to increase the activity of the sarcoplasmic reticulum Ca(2+)-ATPase in adult ventricular myocytes and to produce functional improvements in contractility in vivo and in vitro. While in vivo experiments are often performed in rat, in vitro manipulation of myocytes has been confined to rabbit and human cells. In the present study we make quantitative comparisons between cultured adult rat and rabbit myocytes in their responses to SERCA2a overexpression using adenoviral vectors. We also compare the strategy of SERCA2a overexpression with that of phospholamban down-regulation, using adenovirus carrying antisense message, as a means to increase SERCA2a activity and enhance contraction and relaxation. Adult myocytes were cultured for 48 h with either vector, and contraction assessed in 2 mM Ca2+, 37 degrees C, at a range of stimulation frequencies. Contraction amplitude was enhanced to a similar degree in either rat or rabbit myocytes at most stimulation frequencies, with SERCA2a overexpression and phospholamban down-regulation approximately equally effective. The maximum effect of either vector was less than that of beta-adrenoceptor agonists. Relaxation was accelerated in rabbit myocytes more strongly than in rat. Phospholamban antisense was slightly less effective than SERCA2a overexpression on relaxation times in rabbit. Increasing stimulation frequency also accelerated relaxation in rat myocytes: this effect was greater than, and additive with, that of SERCA2a overexpression. We conclude that, despite some species-dependent modification, the effects of increased SERCA2a activity are broadly similar in rat and rabbit. Both SERCA2a overexpression and phospholamban down-regulation are effective strategies, and neither appears to produce supraphysiological stimulatory effects on contraction or relaxation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575311

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility.

Authors:  H He; M Meyer; J L Martin; P M McDonough; P Ho; X Lou; W Y Lew; R Hilal-Dandan; W H Dillmann
Journal:  Circulation       Date:  1999-08-31       Impact factor: 29.690

2.  Comparison of SERCA1 and SERCA2a expressed in COS-1 cells and cardiac myocytes.

Authors:  C Sumbilla; M Cavagna; L Zhong; H Ma; D Lewis; I Farrance; G Inesi
Journal:  Am J Physiol       Date:  1999-12

Review 3.  Na-Ca exchange and Ca fluxes during contraction and relaxation in mammalian ventricular muscle.

Authors:  D M Bers; J W Bassani; R A Bassani
Journal:  Ann N Y Acad Sci       Date:  1996-04-15       Impact factor: 5.691

4.  SERCA1a can functionally substitute for SERCA2a in the heart.

Authors:  Y Ji; E Loukianov; T Loukianova; L R Jones; M Periasamy
Journal:  Am J Physiol       Date:  1999-01

5.  Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes.

Authors:  R J Hajjar; J X Kang; J K Gwathmey; A Rosenzweig
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

6.  Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase.

Authors:  U Schmidt; F del Monte; M I Miyamoto; T Matsui; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Circulation       Date:  2000-02-22       Impact factor: 29.690

7.  Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure.

Authors:  F del Monte; E Williams; D Lebeche; U Schmidt; A Rosenzweig; J K Gwathmey; E D Lewandowski; R J Hajjar
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

8.  Targeting phospholamban by gene transfer in human heart failure.

Authors:  Federica del Monte; Sian E Harding; G William Dec; Judith K Gwathmey; Roger J Hajjar
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

9.  Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts.

Authors:  D L Baker; K Hashimoto; I L Grupp; Y Ji; T Reed; E Loukianov; G Grupp; A Bhagwhat; B Hoit; R Walsh; E Marban; M Periasamy
Journal:  Circ Res       Date:  1998 Dec 14-28       Impact factor: 17.367

10.  Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

Authors:  W Luo; I L Grupp; J Harrer; S Ponniah; G Grupp; J J Duffy; T Doetschman; E G Kranias
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

View more
  3 in total

Review 1.  Cardiac contractility modulation therapy in advanced systolic heart failure.

Authors:  Alexander R Lyon; Michael A Samara; David S Feldman
Journal:  Nat Rev Cardiol       Date:  2013-08-13       Impact factor: 32.419

2.  Effect of overexpressed adenylyl cyclase VI on beta 1- and beta 2-adrenoceptor responses in adult rat ventricular myocytes.

Authors:  Joalice C C Stark; Stephen F Haydock; Roger Foo; Morris J Brown; Sian E Harding
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

Review 3.  Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy.

Authors:  T Jake Samuel; Ryan P Rosenberry; Seungyong Lee; Zui Pan
Journal:  Int J Mol Sci       Date:  2018-04-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.